Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00714636 · ClinicalTrials.gov registry record

Cerebrospinal Fluid Repository

A clinical trial of Amyotrophic Lateral Sclerosis and Motor Neuron Disease, sponsored by Drexel University College of Medicine.

Completed
Registry status
11
Enrollment target
1
Study location

NCT00714636: Completed study of Amyotrophic Lateral Sclerosis and Motor Neuron Disease, sponsored by Drexel University College of Medicine.

NCT00714636 is a study of Amyotrophic Lateral Sclerosis and Motor Neuron Disease that has completed, run by Drexel University College of Medicine. The registered enrollment target is 11 participants, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00714636, a study of Amyotrophic Lateral Sclerosis and Motor Neuron Disease, has completed, sponsored by Drexel University College of Medicine.

COMPLETED
Registry status
11 participants
Enrollment target
1
Study location

Study Summary

The purpose of a CSF repository is to collect samples of spinal fluid from controls and patients with neurologic disorders including but not exclusively ALS, Dementia, CRPS, neuropathies, and other neuromuscular diseases. This CSF repository will allow the use of CSF in biochemical studies of various neurologic diseases. It would also provide a supply of the necessary normal and disease control patients. CSF would be obtained from patients who are undergoing spinal taps for other reasons including diagnosis, treatment, or participation in clinical trials. We are proposing to collect an additional \< 3 ml of CSF from a lumbar puncture that is already being performed for diagnostic or therapeutic reasons, in order to store it in our laboratory for use in future research studies. No lumbar punctures will be initiated specifically for this protocol.

Study Locations (1)

Pennsylvania

  • MDA/ALS Center of Hope - Philadelphia

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2006-10
Est. Completion 2008-10

What the finished NCT00714636 record still lists

NCT00714636 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 898-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT00714636 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00714636 about?

NCT00714636 is a clinical study titled "Cerebrospinal Fluid Repository". The purpose of a CSF repository is to collect samples of spinal fluid from controls and patients with neurologic disorders including but not exclusively ALS, Dementia, CRPS, neuropathies, and other neuromuscular diseases. This CSF repository will allow the use of CSF in biochemical studies of variou...

What is the current status of trial NCT00714636?

This trial is currently completed. The enrollment target is 11 participants. The study started on 2006-10. Estimated completion is 2008-10.

What conditions does trial NCT00714636 study?

This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Neuro-Degenerative Disease, Cerebrospinal Fluid.

Who is sponsoring clinical trial NCT00714636?

This trial is sponsored by Drexel University College of Medicine, which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00714636 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amyotrophic Lateral Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00714636's enrollment target sits among peer trials

11 90th of 102 higher than 13 of 102 other Amyotrophic Lateral Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Amyotrophic Lateral Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00714636, the US trial registry maintained by the National Library of Medicine. NCT00714636 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.